EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer

Karin van der Tuin iD, Dina Ruano iD, Jeroen Knijnenburg, Rob B van der Luijt, Hans Morreau, Thera P Links iD, Frederik J Hes, Dutch Pediatric Thyroid Cancer Consortium

The Journal of Clinical Endocrinology & Metabolism · 18.11.2024 · 109 (12) · e2214-e2221

DOI: 10.1210/clinem/dgae107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.02.2024. Verfasst von Karin van der Tuin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Germ-Line Mutation, Thyroid Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Kinderen Kankervrij.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The underlying genetic cause of nonmedullary thyroid cancer (NMTC) in children is often unknown, hampering both predictive testing of family members and preventive clinical management.

Objective

Our objectives were to investigated the potential heritability in the largest childhood NMTC cohort that has been genotyped to date.

Methods

Nationwide retrospective cohort study in tertiary referral centers. In total, 97 patients diagnosed with pediatric NMTC between 1970 and 2020 were included in this study. Patients underwent germline whole genome sequencing. The main outcome measures were mutation detection yield in (1) clinically relevant tumor predisposition genes and (2) genes previously associated with NMTC.

Results

In total, 13 of 97 patients (13%) carried a germline (likely) pathogenic variant in a well-known tumor predisposition gene: APC (n = 1), BRCA2 (n = 2), CHEK2 (n = 4), DICER1 (n = 4), HOXB13 (n = 1), and MITF (n = 1). In addition, 1 patient was diagnosed with Pendred syndrome (SLC26A4) and 9 variants of high interest were found in other NMTC candidate susceptibility genes.

Conclusion

The reported prevalence (13%) of germline variants in well-known tumor predisposing genes and the added value of a revised personal/family history and histology led us to recommend genetic counseling for all patients with childhood NMTC. The detected tumor predisposition syndromes are associated with a risk for second cancers which necessitates additional surveillance of the index patients and presymptomatic genetic testing of at risk family members.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationThyroid NeoplasmsGenetic Predisposition to DiseaseHumansMaleFemaleChildRetrospective StudiesAdolescentChild, PreschoolBRCA2 ProteinCheckpoint Kinase 2InfantGenetic TestingWhole Genome SequencingAdenomatous Polyposis Coli ProteinRibonuclease IIIDEAD-box RNA Helicases

Stichwörter der Autor:innen

geneticsheritabilitynonmedullary thyroid cancerpediatrics

Substanzen

BRCA2 ProteinBRCA2 protein, humanCheckpoint Kinase 2DICER1 protein, humanCHEK2 protein, humanAPC protein, humanAdenomatous Polyposis Coli ProteinRibonuclease IIIDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Endocrinology, Internal Medicine, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
  • Clinical Sciences, Research Group Reproduction and Genetics, Center for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Jette Brussels, Belgium.

ORCID-Profile: Karin van der Tuin, Dina Ruano, Thera P Links

Förderung

  • Stichting Kinderen Kankervrij

Zitieren

APA

van der Tuin, K., Ruano, D., Knijnenburg, J., van der Luijt, R. B., Morreau, H., Links, T. P., Hes, F. J., & Dutch Pediatric Thyroid Cancer Consortium (2024). Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 109(12), e2214-e2221. https://doi.org/10.1210/clinem/dgae107

Vancouver

van der Tuin K, Ruano D, Knijnenburg J, van der Luijt RB, Morreau H, Links TP, et al. Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 2024;109(12):e2214-e2221. doi:10.1210/clinem/dgae107

BibTeX
@article{vanderTuin2024,
  author = {van der Tuin, Karin and Ruano, Dina and Knijnenburg, Jeroen and van der Luijt, Rob B and Morreau, Hans and Links, Thera P and Hes, Frederik J and Dutch Pediatric Thyroid Cancer Consortium, Dutch Pediatric Thyroid Cancer Consortium},
  title = {Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {12},
  pages = {e2214--e2221},
  doi = {10.1210/clinem/dgae107}
}
Kostenlos starten →